OBO_ID (LABEL):	GO_0005856 (cytoskeleton)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC2658734	4/2009	S62-PMC2658734	['caption (table-wrap): table\xa01\n\nvalidated and hypothetic Mirna targetsvalidated Mirna targets in type 2 diabetes and in the Endocrine systemmirnatargetfunctionreferencemir-375myotrophininhibition of Insulin secretion[69]mir-9onecut2 transcription factorinhibition of Glucose-stimulated Insulin Release[70]mir-192e-box repressorstgf-Beta-Induced Matrix Protein Collagen Col1A1 and -2[24]mir-143glut4, Hsl, Fatty Acid-Binding protein Ap2, Ppar-Μ2Adipocyte differentiation[49]hypothetic Mirna targets associated with type 2 diabetesmir-30 familyreceptor for advanced glycation end product, Immediate Early Response 3, Vimentin, Heat-Shock Protein-20Podocyte Apoptosis and Cytoskeletal structure[79,80]Mir-23Bhairy/Enhancer Of The Split Protein (Hes1)downstream target of activated Notch Signalling and Expressed in Nephron segments during development[81,84]mir-15, mir-16wnt and Β-Cateninnephron induction during Embryo Development[75,76]mir-7gy-boxnotch signalling[73,74]mir-4, mir-79Brd-boxmir-2, mir-11k-box\nBiogenesis Of Mirnas starts in the Nucleus (see figure3) where stretches of several kilobases long primary Mirnas (pri-Mirnas) are transcribed from the Genome, 3′- Polyadenylated [covalent Linkage Poly (a) tail of 3′ end of Mirna], 5′- capped [7-methyl guanylate (m7g) cap of 5′ end of Mirna].']	N/A	N/A	[('SO_0000276', 'miRNA', 56, 'miRNA'), ('SO_0000276', 'miRNA', 79, 'miRNA'), ('UBERON_0002049', 'vasculature', 123, 'endocrine'), ('PR_000045358', 'insulin family protein', 198, 'insulin'), ('CHEBI_17234', 'glucose', 266, 'glucose'), ('PR_000045358', 'insulin family protein', 285, 'insulin'), ('GO_0006260', 'DNA replication', 293, 'release'), ('PR_000004670', 'protein PTHB1', 330, '-beta-induced matrix protein collagen'), ('GO_0031012', 'extracellular matrix', 344, 'matrix'), ('PR_000003266', 'collagen type II alpha chain', 368, 'Col1a1'), ('PR_000010222', 'muscleblind-like protein 2', 380, '2'), ('PR_000008794', 'heat shock factor protein 5', 399, 'HSL'), ('CHEBI_35366', 'fatty acid', 404, 'fatty acid'), ('PR_000010000', 'lysozyme g-like protein 2', 414, '-binding'), ('PR_000004123', 'adenomatous polyposis coli protein 2', 431, 'aP2'), ('PR_000013031', 'periostin', 436, 'PPAR-μ2Adipocyte'), ('SO_0000276', 'miRNA', 483, 'miRNA'), ('PR_000000035', 'BMP receptor type-1A', 531, '-30'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 586, 'immediate early response 3'), ('PR_000017283', 'vitamin D3 receptor', 614, 'vimentin'), ('PR_000005163', 'CD2-associated protein', 624, 'heat-shock protein-20Podocyte'), ('GO_0006915', 'apoptotic process', 654, 'apoptosis'), ('GO_0005856', 'cytoskeleton', 668, 'cytoskeletal'), ('PR_000002103', 'sodium channel protein type 8 subunit alpha', 697, 'miR-23bHairy'), ('PR_000006890', 'enhancer of mRNA-decapping protein 3', 710, 'enhancer of the split protein'), ('SO_0000165', 'enhancer', 710, 'enhancer'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 741, 'Hes1'), ('GO_0038189', 'neuropilin signaling pathway', 777, 'Notch signalling'), ('GO_0010467', 'gene expression', 798, 'expressed'), ('UBERON_0001285', 'nephron', 811, 'nephron'), ('PR_000002198', 'catenin beta-1', 875, 'β-cateninNephron'), ('GO_0009790', 'embryo development', 909, 'embryo development'), ('UBERON_0000922', 'embryo', 909, 'embryo'), ('PR_000011040', 'nuclear receptor coactivator 1', 979, '79Brd'), ('PR_000010222', 'muscleblind-like protein 2', 992, '2'), ('GO_0070277', 'iodide oxidation', 1007, 'Biogenesis of miRNAs'), ('SO_0000276', 'miRNA', 1021, 'miRNAs'), ('GO_0005634', 'nucleus', 1042, 'nucleus'), ('SO_0000276', 'miRNA', 1114, 'miRNAs'), ('SO_0000276', 'miRNA', 1126, 'miRNAs'), ('SO_0001026', 'genome', 1159, 'genome'), ('GO_0043651', 'linoleic acid metabolic process', 1171, 'polyadenylated'), ('SO_0000987', 'linear', 1196, 'linkage'), ('SO_0000610', 'polyA_sequence', 1204, 'poly'), ('SO_0000276', 'miRNA', 1231, 'miRNA'), ('SO_0000276', 'miRNA', 1293, 'miRNA')]
PMC2888576	6/2010	S166-PMC2888576	['thirteen abundantly Expressed Genes selected from the complete list of 53 Genes (supplementaltable s1) were associated with the Cytoskeleton, e. g. Tubulin, Vimentin (seefig.']	N/A	N/A	[('GO_0010467', 'gene expression', 20, 'expressed'), ('SO_0000704', 'gene', 30, 'genes'), ('SO_0000704', 'gene', 74, 'genes'), ('GO_0005856', 'cytoskeleton', 128, 'cytoskeleton'), ('PR_000028799', 'tubulin', 148, 'tubulin'), ('PR_000017283', 'vitamin D3 receptor', 157, 'vimentin')]
PMC3322122	4/2012	S50-PMC3322122	['of Genes involvedgenes involved in pathway94 dpcactin Cytoskeleton signalingup1.02*e-27Acta1, Cdc42, Msn, Rdx, Ssh2, Ttn, Vclg1/s checkpoint Regulationup2.48*e-23cdk6, E2F2, Hdac6Cyclin and Cell Cycle Regulationup1.19*e-24cdk6, E2F2, Hdac6, Ppp2R1Aorganisation of filamentsup1.53*e-48col1a1, Col1A2, Col5A1, lox, Msn, Nck2, rdx, Rhob1 dpnorganisation of filamentsup1.03*e-710akap2, Col1A1, Col1A2, Col5A1, Col5A2, Dcn, Fn1, lox, P4Ha1, Serpinh128 dpn-----188 dpn-----\nup and down indicate higher and lower abundance in hp compared to ap, respectively.']	N/A	N/A	[('SO_0000704', 'gene', 3, 'genes'), ('GO_0005856', 'cytoskeleton', 54, 'cytoskeleton'), ('PR_000010090', 'protein MAK10', 85, '27ACTA1'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 94, 'CDC42'), ('PR_000010718', 'metal-response element-binding transcription factor 2', 101, 'MSN'), ('PR_000013890', 'arginine-glutamic acid dipeptide repeats protein', 106, 'RDX'), ('PR_000015693', 'suppressor of tumorigenicity 7 protein', 111, 'SSH2'), ('PR_000016850', 'tyrosine-protein kinase TXK', 117, 'TTN'), ('PR_000017279', 'testis-specific basic protein Y 1', 122, 'VCLG1'), ('PR_000013990', 'rhophilin-1', 141, 'regulationup2'), ('PR_000006853', 'transcription factor E2F2', 168, 'E2F2'), ('PR_000008453', 'hepatitis A virus cellular receptor 1', 174, 'HDAC6Cyclin'), ('GO_0070370', 'cellular heat acclimation', 190, 'cell cycle regulationup1'), ('PR_000006853', 'transcription factor E2F2', 228, 'E2F2'), ('PR_000008488', 'histone deacetylase 9', 234, 'HDAC6'), ('PR_000013433', 'parathyroid hormone-related protein', 241, 'PPP2R1AOrganisation'), ('PR_000003266', 'collagen type II alpha chain', 292, 'COL1A2'), ('PR_000003266', 'collagen type II alpha chain', 300, 'COL5A1'), ('PR_000010718', 'metal-response element-binding transcription factor 2', 313, 'MSN'), ('PR_000011040', 'nuclear receptor coactivator 1', 318, 'NCK2'), ('PR_000013939', 'Ral-GDS-related protein', 329, 'RHOB1'), ('PR_000003266', 'collagen type II alpha chain', 382, 'COL1A1'), ('PR_000003266', 'collagen type II alpha chain', 390, 'COL1A2'), ('PR_000003266', 'collagen type II alpha chain', 398, 'COL5A1'), ('PR_000005703', 'collagen alpha-1(XIX) chain', 406, 'COL5A2'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 414, 'DCN'), ('PR_000007581', 'fibronectin', 419, 'FN1'), ('PR_000012190', 'P2X purinoceptor 3', 429, 'P4HA1'), ('PR_000014660', 'septin-8', 436, 'SERPINH128')]
PMC3482177	10/2012	S163-PMC3482177	['a number of chaperone proteins that were down-regulated following exposure to a Prenatal fed diet are involved in Folding of Cytoskeletal components (chaperonin) and other targets of interest such as P53 (Nucleophosmin).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 80, 'prenatal'), ('GO_0006457', 'protein folding', 114, 'folding'), ('GO_0005856', 'cytoskeleton', 125, 'cytoskeletal'), ('PR_000003035', 'cellular tumor antigen p53', 200, 'p53'), ('PR_000011509', 'nuclear pore complex protein Nup155', 205, 'nucleophosmin')]
PMC3781185	7/2013	S46-PMC3781185	['739-47)\nTensin3 is a Cytoskeletal Regulatory protein that inhibits Cell Motility.']	N/A	N/A	[('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 8, 'Tensin3'), ('GO_0005856', 'cytoskeleton', 21, 'cytoskeletal'), ('GO_0065007', 'biological regulation', 34, 'regulatory'), ('GO_0048870', 'cell motility', 67, 'cell motility')]
PMC4258799	11/2014	S58-PMC4258799	['in the Oocyte, Ros levels when present in excess, can disrupt the Oocyte Cytoskeleton, alter Microtubule function, cause chromosomal scattering and aneuploidy [5].']	N/A	N/A	[('CL_0000023', 'oocyte', 7, 'oocyte'), ('CHEBI_8756', 'RNA (poly(A))', 15, 'ROS'), ('CL_0000023', 'oocyte', 66, 'oocyte'), ('GO_0005856', 'cytoskeleton', 73, 'cytoskeleton'), ('GO_0005874', 'microtubule', 93, 'microtubule')]
PMC4258799	11/2014	S133-PMC4258799	['both 0.3\xa0mg/ml and 0.6\xa0mg/ml\xa0L-Carnitine reduced the blocking effect of Actinomycin-D, Hydrogen Peroxide or tumor Necrosis Factor Alpha and reduced the level of dna damage\n\nph and temperature\nIntracellular Homeostasis is highly susceptible to changes in ph (most occur within a ph of 6 to 8), especially key processes such as Protein Synthesis, Mitochondrial function, Cytoskeletal Regulation and Cellular Metabolism [68].']	N/A	N/A	[('CHEBI_16533', 'L-tryptophanamide', 29, 'L-carnitine'), ('CHEBI_28618', '1,4-dichlorobenzene', 72, 'actinomycin-D'), ('CHEBI_16240', 'hydrogen peroxide', 87, 'hydrogen peroxide'), ('PR_000011193', 'ephexin-1', 114, 'necrosis factor alpha'), ('GO_0005622', 'intracellular anatomical structure', 192, 'Intracellular'), ('GO_0071836', 'nectar secretion', 192, 'Intracellular homeostasis'), ('GO_0006412', 'translation', 326, 'protein synthesis'), ('GO_0005739', 'mitochondrion', 345, 'mitochondrial'), ('GO_0005856', 'cytoskeleton', 369, 'cytoskeletal'), ('GO_0065007', 'biological regulation', 382, 'regulation'), ('GO_0044237', 'cellular metabolic process', 397, 'cellular metabolism')]
PMC4595656	10/2015	S102-PMC4595656	['there was a concurrent 16-fold increase in levels of Bcl2, a protein marker of Cell Differentiation, and Nf-L, one of the Neurofilaments involved in maintenance and remodeling of the Neuronal Cytoskeleton.']	N/A	N/A	[('PR_000004689', 'B-cell lymphoma/leukemia 10', 53, 'Bcl2'), ('GO_0030154', 'cell differentiation', 79, 'cell differentiation'), ('GO_0005883', 'neurofilament', 105, 'NF'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 105, 'NF-L'), ('GO_0005883', 'neurofilament', 122, 'neurofilaments'), ('CL_0000540', 'neuron', 183, 'neuronal'), ('GO_0005856', 'cytoskeleton', 192, 'cytoskeleton')]
PMC4806285	3/2016	S75-PMC4806285	['impact of stress and gc on neurodegenerative mechanisms of ad\nat the molecular level, ad pathology is characterized by Amyloid Beta (A Β ) that forms deposits (senile plaques) and hyperphosphorylated forms of the Cytoskeletal protein Tau that aggregate into Neurofibrillary Tangles (Nft) [69–71].']	N/A	N/A	[('CHEBI_60425', 'amyloid fibril', 119, 'amyloid'), ('PR_000003905', 'aldo-keto reductase family 1 member C3', 119, 'amyloid beta'), ('PR_000004155', 'apolipoprotein E', 133, 'A β'), ('GO_0005856', 'cytoskeleton', 213, 'cytoskeletal'), ('PR_000010173', 'microtubule-associated protein tau', 234, 'Tau'), ('GO_0097418', 'neurofibrillary tangle', 258, 'neurofibrillary tangles'), ('GO_0005883', 'neurofilament', 283, 'NFT')]
PMC4829879	2/2016	S107-PMC4829879	['results were normalized to protein content of Tissue homogenate, as determined by precision red assay (Cytoskeleton, denver, co).']	N/A	N/A	[('UBERON_0000479', 'tissue', 46, 'tissue'), ('GO_0005856', 'cytoskeleton', 103, 'Cytoskeleton')]
PMC4989298	8/2016	S476-PMC4989298	['mites release numerous Allergens in the environment, including cysteine protease ( Der P 1, der f 1), serine proteases ( Der P 3, 6 and 9), glycosidases, Carbohydrate binding proteins, calcium-binding proteins, muscle proteins and Cytoskeleton.']	N/A	N/A	[('CHEBI_33663', 'cyclic hydrocarbon', 23, 'allergens'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 83, 'Der p 1'), ('PR_000006603', 'dynamin-2', 121, 'Der p 3'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 154, 'carbohydrate'), ('GO_0005856', 'cytoskeleton', 231, 'cytoskeleton')]
PMC5470056	4/2017	S151-PMC5470056	['each Eye is composed of 12 Photoreceptor Neurons (Prs), which are further divided into two subclasses based on the Rhodopsin Gene they Express: four Photoreceptors Express the blue-sensitive Rhodopsin5 (rh5-Prs) and eight Photoreceptors Express green-sensitive Rhodopsin6 (rh6-Prs) [100].']	N/A	N/A	[('UBERON_0000970', 'eye', 5, 'eye'), ('CL_0000210', 'photoreceptor cell', 27, 'photoreceptor neurons'), ('CL_0000670', 'primordial germ cell', 50, 'PRs'), ('PR_000001245', 'rhodopsin', 115, 'rhodopsin'), ('SO_0000704', 'gene', 125, 'gene'), ('GO_0010467', 'gene expression', 135, 'express'), ('CL_0000210', 'photoreceptor cell', 149, 'photoreceptors'), ('GO_0010467', 'gene expression', 164, 'express'), ('PR_000001245', 'rhodopsin', 191, 'rhodopsin5'), ('GO_0005856', 'cytoskeleton', 207, 'PRs'), ('CL_0000210', 'photoreceptor cell', 222, 'photoreceptors'), ('GO_0010467', 'gene expression', 237, 'express'), ('PR_000001245', 'rhodopsin', 261, 'rhodopsin6'), ('GO_0005856', 'cytoskeleton', 277, 'PRs')]
PMC5804559	10/2017	S98-PMC5804559	['caption (table-wrap): table 5:\n\na functional annotation comparison of up and downregulated Genes at each generationf0f1f2f3go categorygo term n \u2009=\u20091074 n \u2009=\u20091867 n \u2009=\u2009541 n \u2009=\u20091684 n \u2009=\u200917 n \u2009=\u200922 n \u2009=\u20091893 n \u2009=\u20092720↑ Expression in hplc↓ Expressison in hplc↓ Expression in mm↑ Expression in mm↓ Expression in mm↑ Expression in mm↓ Expression in mm↑ Expression in mm Biological Process# Genes % of total # Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes % of total\u2003biological adhesiongo: 002261030.30341.9010.20291.9017.1070.40351.50\u2003biological Regulationgo: 0065007807.601277.00255.101097.2014.501437.501757.40\u2003cellular component organization or biogenesisgo: 0071840938.90633.50367.30513.4014.501769.20984.10\u2003Cellular processgo: 000998737035.3047526.3016433.5038325.50214.30418.2069636.3060225.50\u2003developmental processgo: 0032502373.501045.80112.20895.9029.10703.601476.20\u2003Immune System processgo: 0002376101.00261.4051.00251.70160.80331.40\u2003localizationgo: 0051179787.401397.70255.101308.60214.3029.101517.901948.20\u2003Locomotiongo: 004001140.4010.1020.4010.1060.3010.00\u2003Metabolic processgo: 000815238336.5039321.8017936.5032821.80535.70522.7070836.9050821.50\u2003multicellular Organismal processgo: 0032501181.701277.0061.20906.0029.10281.501626.90\u2003reproductiongo: 0000003161.50301.7091.80241.6014.50281.50361.50\u2003response to stimulusgo: 0050896757.201246.90336.701067.0014.501407.301667.00\u2003Rhythmic processgo: 0048511140.8010.20130.9014.5010.10140.60 protein class# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total \u2003Calcium-Binding proteinpc0006040.40271.5010.20140.90170.90351.50\u2003Cell Adhesion Moleculepc0006920.20241.30161.1050.30301.30\u2003Cell Junction proteinpc0007030.30%80.40100.7050.30140.60\u2003chaperonepc0007280.80%30.2020.40%30.20140.7070.30\u2003Cytoskeletal proteinpc00085413.90%442.40173.50%382.50593.10592.50\u2003defense/immunity proteinpc0009020.20%80.4010.20%70.5070.40100.40\u2003enzyme modulatorpc00095424.00%593.30142.90%513.4014.50%1015.30723.00\u2003Extracellular Matrix proteinpc00102221.20161.1030.20261.10\u2003hydrolasepc00121737.00%1448.00306.10%1318.70428.60%29.10%1427.401817.70\u2003isomerasepc0013550.50%50.3080.50130.7070.30\u2003ligasepc00142242.30%201.1081.60%151.0017.10%14.50%482.50251.10\u2003lyasepc0014440.40%281.60201.30150.80251.10\u2003Membrane Traffic proteinpc0015060.60%160.90151.00140.70210.90\u2003Nucleic Acid bindingpc0017116415.60%724.008818.00%604.0029615.401345.70\u2003oxidoreductasepc00176212.00%945.20122.40%674.50432.20964.10\u2003receptorpc00197121.10%814.5051.00%644.3017.10%281.501074.50\u2003signalling Moleculepc00207121.10%563.1030.60%493.3014.50%241.30723.00\u2003storage proteinpc0021030.30%70.4020.40%40.3050.3080.30\u2003structural proteinpc0021120.2020.1010.2030.2070.4030.10\u2003transcription factorpc00218817.70683.80336.70%593.901306.801175.00\u2003transfer/carrier proteinpc00219131.20%362.0010.20%312.10281.50512.20\u2003transferasepc00220625.90%563.10255.10%493.3014.50%1316.80662.80\u2003Transmembrane receptor Regulatory/adaptor proteinpc0022610.10%60.3081.60%40.3030.2050.20\u2003transporterpc00227282.70%1407.801087.20472.501687.10\u2003Viral proteinpc0023710.10 molecular function# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total# Genes% of total \u2003antioxidant activitygo: 001620920.2090.5030.6070.5050.30120.50\u2003bindinggo: 000548825824.6024013.3011723.9020113.4017.10%14.50%45523.7034914.80\u2003catalytic activitygo: 000382426525.3041222.8012325.1035223.40%535.70%418.20%52427.3048320.40\u2003channel regulator activitygo: 001624710.00\u2003receptor activitygo: 000487280.80543.0051.00473.1017.10180.90743.10\u2003signal transducer activitygo: 000487130.30120.7010.2080.5070.40190.80\u2003structural Molecule activitygo: 0005198222.10643.5061.20442.90452.30873.70\u2003Translation regulator activitygo: 004518220.2010.1010.201157.6090.5030.10\u2003transporter activitygo: 0005215343.201498.30132.7017.1014.50583.001777.50\nup- and down-regulated Genes at each generation were submitted to panther for an analysis of their annotated function.']	N/A	N/A	[('SO_0000704', 'gene', 91, 'genes'), ('GO_0010467', 'gene expression', 218, 'expression'), ('GO_0010467', 'gene expression', 238, 'expressison'), ('GO_0010467', 'gene expression', 259, 'expression'), ('GO_0010467', 'gene expression', 277, 'expression'), ('GO_0010467', 'gene expression', 295, 'expression'), ('GO_0010467', 'gene expression', 313, 'expression'), ('GO_0010467', 'gene expression', 331, 'expression'), ('GO_0010467', 'gene expression', 349, 'expression'), ('GO_0006915', 'apoptotic process', 366, 'Biological process'), ('SO_0000704', 'gene', 386, 'genes'), ('SO_0000704', 'gene', 405, 'genes'), ('SO_0000704', 'gene', 422, 'genes'), ('SO_0000704', 'gene', 439, 'genes'), ('SO_0000704', 'gene', 456, 'genes'), ('SO_0000704', 'gene', 473, 'genes'), ('SO_0000704', 'gene', 490, 'genes'), ('SO_0000704', 'gene', 507, 'genes'), ('GO_0050818', 'regulation of coagulation', 604, 'regulationGO'), ('GO_0007049', 'cell cycle', 770, 'Cellular'), ('UBERON_0002410', 'autonomic nervous system', 934, 'Immune system'), ('GO_0061440', 'kidney vasculature development', 1077, 'LocomotionGO'), ('GO_0008152', 'metabolic process', 1129, 'Metabolic'), ('NCBITaxon_1', 'root', 1232, 'organismal'), ('GO_0046334', 'octopamine catabolic process', 1445, 'Rhythmic'), ('SO_0000704', 'gene', 1521, 'genes'), ('SO_0000704', 'gene', 1538, 'genes'), ('SO_0000704', 'gene', 1555, 'genes'), ('SO_0000704', 'gene', 1572, 'genes'), ('SO_0000704', 'gene', 1589, 'genes'), ('SO_0000704', 'gene', 1606, 'genes'), ('SO_0000704', 'gene', 1623, 'genes'), ('SO_0000704', 'gene', 1640, 'genes'), ('CHEBI_31341', 'calcium dihydroxide', 1657, 'Calcium'), ('PR_000010000', 'lysozyme g-like protein 2', 1664, '-binding'), ('PR_000009339', 'killer cell immunoglobulin-like receptor 3DL3', 1722, 'Cell adhesion moleculePC0006920'), ('CHEBI_53706', 'phenoxymethylpenicillanyl group', 1736, 'moleculePC0006920'), ('GO_0030054', 'cell junction', 1780, 'Cell junction'), ('GO_0005856', 'cytoskeleton', 1887, 'Cytoskeletal'), ('GO_0031012', 'extracellular matrix', 2087, 'Extracellular matrix'), ('GO_0016020', 'membrane', 2368, 'Membrane'), ('GO_0055085', 'transmembrane transport', 2368, 'Membrane traffic'), ('CHEBI_17497', 'glycolic acid', 2430, 'Nucleic acid'), ('GO_0005634', 'nucleus', 2430, 'Nucleic'), ('CHEBI_53726', 'procion red MX-5B', 2633, 'moleculePC00207121'), ('GO_0032588', 'trans-Golgi network membrane', 3003, 'Transmembrane'), ('GO_0065007', 'biological regulation', 3026, 'regulatory'), ('NCBITaxon_10088', 'Mus <genus>', 3145, 'Viral'), ('SO_0000704', 'gene', 3191, 'genes'), ('SO_0000704', 'gene', 3208, 'genes'), ('SO_0000704', 'gene', 3225, 'genes'), ('SO_0000704', 'gene', 3242, 'genes'), ('SO_0000704', 'gene', 3259, 'genes'), ('SO_0000704', 'gene', 3276, 'genes'), ('SO_0000704', 'gene', 3293, 'genes'), ('SO_0000704', 'gene', 3310, 'genes'), ('CHEBI_36357', 'polyatomic entity', 3754, 'molecule'), ('GO_0006412', 'translation', 3818, 'Translation'), ('SO_0000704', 'gene', 3989, 'genes')]
